ABG
Ally Bridge Group Portfolio holdings
AUM
$114M
This Quarter Return
-6.59%
1 Year Return
+41.64%
3 Year Return
+246.39%
5 Year Return
–
10 Year Return
–
AUM
$151M
AUM Growth
+$151M
(+38%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
15.74%
Top 10 Holdings %
Top 10 Hldgs %
53.82%
Holding
52
New
30
Increased
–
Reduced
7
Closed
13
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$12.7M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$8.99M |
| 3 |
Sanofi
SNY
|
$8.75M |
| 4 |
Karyopharm Therapeutics
KPTI
|
$8.35M |
| 5 |
Ironwood Pharmaceuticals
IRWD
|
$7.69M |
Top Sells
| 1 |
Cogent Biosciences
COGT
|
$9.75M |
| 2 |
argenx
ARGX
|
$9.58M |
| 3 |
Lantheus
LNTH
|
$7.59M |
| 4 |
Guardant Health
GH
|
$6.45M |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$6.25M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Guardant Health
GH
$8.11B
| – | – |
-160,000
| Closed | -$6.45M |
|
52
Fate Therapeutics
FATE
$115M
| – | – |
-181,500
| Closed | -$4.5M |
|